Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 13, 2023 Filed Apr 17, 2023 21:28 UTC |
Szekeres David LeslieEVP, Chief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-024500 · doc4.xml · derivative · entry 4 Szekeres David Leslie · CIK 0001602459 · EVP, Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 1,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020). F3 · derivative.expiration_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020). Read SEC document |
| April 13, 2023 Filed Apr 17, 2023 21:28 UTC |
Szekeres David LeslieEVP, Chief Operating Officer
|
Tax withholdingCommon Stock | 2,012 | $2.88 | $5,794.56 |
DisclosureSEC source: 0001209191-23-024500 · doc4.xml · nonDerivative · entry 3 Szekeres David Leslie · CIK 0001602459 · EVP, Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,952 F2 · acquired: Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions. Read SEC document |
| April 13, 2023 Filed Apr 17, 2023 21:28 UTC |
Szekeres David LeslieEVP, Chief Operating Officer
|
Exercise / conversionCommon Stock | 4,564 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-024500 · doc4.xml · nonDerivative · entry 2 Szekeres David Leslie · CIK 0001602459 · EVP, Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,964 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| April 13, 2023 Filed Apr 17, 2023 21:28 UTC |
Szekeres David LeslieEVP, Chief Operating Officer
|
Exercise / conversionCommon Stock | 1,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-024500 · doc4.xml · nonDerivative · entry 1 Szekeres David Leslie · CIK 0001602459 · EVP, Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,400 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| April 13, 2023 Filed Apr 17, 2023 21:27 UTC |
POYHONEN JOHNPresident & CCO
|
Exercise / conversionRestricted Stock Units · Derivative | 4,564 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-024499 · doc4.xml · derivative · entry 5 POYHONEN JOHN · CIK 0001286100 · President & CCO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,936 Underlying: Common Stock · 4,564 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021). F4 · derivative.expiration_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021). Read SEC document |
| April 13, 2023 Filed Apr 17, 2023 21:27 UTC |
POYHONEN JOHNPresident & CCO
|
Exercise / conversionRestricted Stock Units · Derivative | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-024499 · doc4.xml · derivative · entry 4 POYHONEN JOHN · CIK 0001286100 · President & CCO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 1,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020). F3 · derivative.expiration_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020). Read SEC document |
| April 13, 2023 Filed Apr 17, 2023 21:27 UTC |
POYHONEN JOHNPresident & CCO
|
Tax withholdingCommon Stock | 2,012 | $2.88 | $5,794.56 |
DisclosureSEC source: 0001209191-23-024499 · doc4.xml · nonDerivative · entry 3 POYHONEN JOHN · CIK 0001286100 · President & CCO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,648 F2 · acquired: Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions. Read SEC document |
| April 13, 2023 Filed Apr 17, 2023 21:27 UTC |
POYHONEN JOHNPresident & CCO
|
Exercise / conversionCommon Stock | 4,564 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-024499 · doc4.xml · nonDerivative · entry 2 POYHONEN JOHN · CIK 0001286100 · President & CCO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,660 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| April 13, 2023 Filed Apr 17, 2023 21:27 UTC |
POYHONEN JOHNPresident & CCO
|
Exercise / conversionCommon Stock | 1,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-024499 · doc4.xml · nonDerivative · entry 1 POYHONEN JOHN · CIK 0001286100 · President & CCO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,096 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| April 13, 2023 Filed Apr 17, 2023 21:27 UTC |
Peraza LisaVP, Chief Accounting Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,932 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-024498 · doc4.xml · derivative · entry 5 Peraza Lisa · CIK 0001828266 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,829 Underlying: Common Stock · 1,932 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021). F4 · derivative.expiration_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021). Read SEC document |
| April 13, 2023 Filed Apr 17, 2023 21:27 UTC |
Peraza LisaVP, Chief Accounting Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 552 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-024498 · doc4.xml · derivative · entry 4 Peraza Lisa · CIK 0001828266 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,312 Underlying: Common Stock · 552 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020). F3 · derivative.expiration_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020). Read SEC document |
| April 13, 2023 Filed Apr 17, 2023 21:27 UTC |
Peraza LisaVP, Chief Accounting Officer
|
Tax withholdingCommon Stock | 860 | $2.88 | $2,476.80 |
DisclosureSEC source: 0001209191-23-024498 · doc4.xml · nonDerivative · entry 3 Peraza Lisa · CIK 0001828266 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,685 F2 · acquired: Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions. Read SEC document |
| April 13, 2023 Filed Apr 17, 2023 21:27 UTC |
Peraza LisaVP, Chief Accounting Officer
|
Exercise / conversionCommon Stock | 1,932 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-024498 · doc4.xml · nonDerivative · entry 2 Peraza Lisa · CIK 0001828266 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,545 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| April 13, 2023 Filed Apr 17, 2023 21:27 UTC |
Peraza LisaVP, Chief Accounting Officer
|
Exercise / conversionCommon Stock | 552 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-024498 · doc4.xml · nonDerivative · entry 1 Peraza Lisa · CIK 0001828266 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,613 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| April 13, 2023 Filed Apr 17, 2023 21:26 UTC |
MANHARD KIMBERLYEVP, Drug Development
|
Exercise / conversionRestricted Stock Units · Derivative | 4,564 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-024497 · doc4.xml · derivative · entry 5 MANHARD KIMBERLY · CIK 0001202094 · EVP, Drug Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,936 Underlying: Common Stock · 4,564 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021). F4 · derivative.expiration_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021). Read SEC document |
| April 13, 2023 Filed Apr 17, 2023 21:26 UTC |
MANHARD KIMBERLYEVP, Drug Development
|
Exercise / conversionRestricted Stock Units · Derivative | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-024497 · doc4.xml · derivative · entry 4 MANHARD KIMBERLY · CIK 0001202094 · EVP, Drug Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 1,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020). F3 · derivative.expiration_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020). Read SEC document |
| April 13, 2023 Filed Apr 17, 2023 21:26 UTC |
MANHARD KIMBERLYEVP, Drug Development
|
Tax withholdingCommon Stock | 1,417 | $2.88 | $4,080.96 |
DisclosureSEC source: 0001209191-23-024497 · doc4.xml · nonDerivative · entry 3 MANHARD KIMBERLY · CIK 0001202094 · EVP, Drug Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,330 F2 · acquired: Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions. Read SEC document |
| April 13, 2023 Filed Apr 17, 2023 21:26 UTC |
MANHARD KIMBERLYEVP, Drug Development
|
Exercise / conversionCommon Stock | 4,564 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-024497 · doc4.xml · nonDerivative · entry 2 MANHARD KIMBERLY · CIK 0001202094 · EVP, Drug Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,747 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| April 13, 2023 Filed Apr 17, 2023 21:26 UTC |
MANHARD KIMBERLYEVP, Drug Development
|
Exercise / conversionCommon Stock | 1,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-024497 · doc4.xml · nonDerivative · entry 1 MANHARD KIMBERLY · CIK 0001202094 · EVP, Drug Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,183 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| April 03, 2023 Filed Apr 5, 2023 21:10 UTC |
Collard Craig ADirector · Chief Executive Officer
|
GrantEmployee Performance Stock Option (Right to Buy) · Derivative | 4,250,000 | $0.00 Strike: $1.78 | $0.00 |
DisclosureSEC source: 0001209191-23-023385 · doc4.xml · derivative · entry 3 Collard Craig A · CIK 0001363558 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,250,000 Underlying: Common Stock · 4,250,000 shares Expires 2033-04-03 F3 · derivative.exercise_date: The stock option vests and becomes exercisable with respect to escalating portions of the option grant upon the Issuer's stock price reaching certain pre-established levels ranging from $4.50 to $9.00 per share, subject to the Reporting Person's continued service to the Issuer through the vesting date. Read SEC document |
| April 03, 2023 Filed Apr 5, 2023 21:10 UTC |
Collard Craig ADirector · Chief Executive Officer
|
GrantRestricted Stock Units · Derivative | 250,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-023385 · doc4.xml · derivative · entry 2 Collard Craig A · CIK 0001363558 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires not disclosed F2 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning one year after the date of grant, subject to the Reporting Person's continued service to the Issuer through the vesting date. F2 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning one year after the date of grant, subject to the Reporting Person's continued service to the Issuer through the vesting date. Read SEC document |
| April 03, 2023 Filed Apr 5, 2023 21:10 UTC |
Collard Craig ADirector · Chief Executive Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 3,000,000 | $0.00 Strike: $1.78 | $0.00 |
DisclosureSEC source: 0001209191-23-023385 · doc4.xml · derivative · entry 1 Collard Craig A · CIK 0001363558 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,000,000 Underlying: Common Stock · 3,000,000 shares Expires 2033-04-03 F1 · derivative.exercise_date: The stock option vests and becomes exercisable with respect to 750,000 shares on the first anniversary of the date of grant, followed by 2,250,000 shares vesting ratably each month over the subsequent three years, such that 3,000,000 options will be fully vested on the four-year anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer through the vesting date. Read SEC document |
| February 22, 2023 Filed Feb 25, 2023 00:20 UTC |
Morgan AdamDirector · See Notes 2 & 3
|
GrantStock Option (Right to Buy) · Derivative | 227,272 | $0.00 Strike: $2.70 | $0.00 |
DisclosureSEC source: 0001209191-23-012924 · doc4.xml · derivative · entry 3 Morgan Adam · CIK 0001964335 · Director · See Notes 2 & 3 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 227,272 Underlying: Common Stock · 227,272 shares Expires 2033-02-22 F4 · derivative.exercise_date: The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the date of grant (02/22/2023). Read SEC document |
| February 22, 2023 Filed Feb 25, 2023 00:20 UTC |
Morgan AdamDirector · See Notes 2 & 3
|
GrantCommon Stock | 37,879 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-012924 · doc4.xml · nonDerivative · entry 1 Morgan Adam · CIK 0001964335 · Director · See Notes 2 & 3 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,879 F1 · shares: The shares were granted as restricted stock units which vest in 16 equal quarterly installments beginning three months after the date of grant (02/22/2023). Read SEC document |
| January 18, 2023 Filed Jan 20, 2023 22:10 UTC |
Szekeres David LeslieEVP, Chief Operating Officer
|
GrantPerformance Stock Units · Derivative | 49,788 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-004304 · doc4.xml · derivative · entry 1 Szekeres David Leslie · CIK 0001602459 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,788 Underlying: Common Stock · 49,788 shares Expires not disclosed F1 · derivative.exercise_date: On July 25, 2022, the Compensation Committee of the Issuer (the "Committee") granted the Reporting Person Performance Stock Units ("PSUs"), the vesting of which was subject to the achievement of certain corporate performance goals and time-based vesting. On January 18, 2023, the Committee determined that certain performance goals of the PSUs had been achieved. The PSUs are further subject to a time-based vesting schedule. The PSUs will vest in full on the first anniversary of the grant date subject to continued employment through such date. Upon vesting and settlement of the PSUs, the Reporting Person will receive a number of shares of common stock of the Issuer equal to the number of PSUs that have vested. F1 · derivative.expiration_date: On July 25, 2022, the Compensation Committee of the Issuer (the "Committee") granted the Reporting Person Performance Stock Units ("PSUs"), the vesting of which was subject to the achievement of certain corporate performance goals and time-based vesting. On January 18, 2023, the Committee determined that certain performance goals of the PSUs had been achieved. The PSUs are further subject to a time-based vesting schedule. The PSUs will vest in full on the first anniversary of the grant date subject to continued employment through such date. Upon vesting and settlement of the PSUs, the Reporting Person will receive a number of shares of common stock of the Issuer equal to the number of PSUs that have vested. Read SEC document |
| January 18, 2023 Filed Jan 20, 2023 22:10 UTC |
Quart Barry DDirector · Chief Executive Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 850,000 | $0.00 Strike: $3.13 | $0.00 |
DisclosureSEC source: 0001209191-23-004303 · doc4.xml · derivative · entry 1 Quart Barry D · CIK 0001384243 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 850,000 Underlying: Common Stock · 850,000 shares Expires 2033-01-18 F1 · derivative.exercise_date: The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the date of grant. Read SEC document |
| January 18, 2023 Filed Jan 20, 2023 22:09 UTC |
POYHONEN JOHNPresident & CCO
|
GrantPerformance Stock Units · Derivative | 66,385 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-004302 · doc4.xml · derivative · entry 1 POYHONEN JOHN · CIK 0001286100 · President & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,385 Underlying: Common Stock · 66,385 shares Expires not disclosed F1 · derivative.exercise_date: On July 25, 2022, the Compensation Committee of the Issuer (the "Committee") granted the Reporting Person Performance Stock Units ("PSUs"), the vesting of which was subject to the achievement of certain corporate performance goals and time-based vesting. On January 18, 2023, the Committee determined that certain performance goals of the PSUs had been achieved. The PSUs are further subject to a time-based vesting schedule. The PSUs will vest in full on the first anniversary of the grant date subject to continued employment through such date. Upon vesting and settlement of the PSUs, the Reporting Person will receive a number of shares of common stock of the Issuer equal to the number of PSUs that have vested. F1 · derivative.expiration_date: On July 25, 2022, the Compensation Committee of the Issuer (the "Committee") granted the Reporting Person Performance Stock Units ("PSUs"), the vesting of which was subject to the achievement of certain corporate performance goals and time-based vesting. On January 18, 2023, the Committee determined that certain performance goals of the PSUs had been achieved. The PSUs are further subject to a time-based vesting schedule. The PSUs will vest in full on the first anniversary of the grant date subject to continued employment through such date. Upon vesting and settlement of the PSUs, the Reporting Person will receive a number of shares of common stock of the Issuer equal to the number of PSUs that have vested. Read SEC document |
| January 18, 2023 Filed Jan 20, 2023 22:09 UTC |
Peraza LisaVP, Chief Accounting Officer
|
GrantPerformance Stock Units · Derivative | 42,631 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-004301 · doc4.xml · derivative · entry 1 Peraza Lisa · CIK 0001828266 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,631 Underlying: Common Stock · 42,631 shares Expires not disclosed F1 · derivative.exercise_date: On July 25, 2022, the Compensation Committee of the Issuer (the "Committee") granted the Reporting Person Performance Stock Units ("PSUs"), the vesting of which was subject to the achievement of certain corporate performance goals and time-based vesting. On January 18, 2023, the Committee determined that certain performance goals of the PSUs had been achieved. The PSUs are further subject to a time-based vesting schedule. The PSUs will vest in full on the first anniversary of the grant date subject to continued employment through such date. Upon vesting and settlement of the PSUs, the Reporting Person will receive a number of shares of common stock of the Issuer equal to the number of PSUs that have vested. F1 · derivative.expiration_date: On July 25, 2022, the Compensation Committee of the Issuer (the "Committee") granted the Reporting Person Performance Stock Units ("PSUs"), the vesting of which was subject to the achievement of certain corporate performance goals and time-based vesting. On January 18, 2023, the Committee determined that certain performance goals of the PSUs had been achieved. The PSUs are further subject to a time-based vesting schedule. The PSUs will vest in full on the first anniversary of the grant date subject to continued employment through such date. Upon vesting and settlement of the PSUs, the Reporting Person will receive a number of shares of common stock of the Issuer equal to the number of PSUs that have vested. Read SEC document |
| January 18, 2023 Filed Jan 20, 2023 22:08 UTC |
MANHARD KIMBERLYDirector · EVP, Drug Development
|
GrantPerformance Stock Units · Derivative | 149,365 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-004299 · doc4.xml · derivative · entry 1 MANHARD KIMBERLY · CIK 0001202094 · Director · EVP, Drug Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,365 Underlying: Common Stock · 149,365 shares Expires not disclosed F1 · derivative.exercise_date: On July 25, 2022, the Compensation Committee of the Issuer (the "Committee") granted the Reporting Person Performance Stock Units ("PSUs"), the vesting of which was subject to the achievement of certain corporate performance goals and time-based vesting. On January 18, 2023, the Committee determined that certain performance goals of the PSUs had been achieved. The PSUs are further subject to a time-based vesting schedule. The PSUs will vest in full on the first anniversary of the grant date subject to continued employment through such date. Upon vesting and settlement of the PSUs, the Reporting Person will receive a number of shares of common stock of the Issuer equal to the number of PSUs that have vested. F1 · derivative.expiration_date: On July 25, 2022, the Compensation Committee of the Issuer (the "Committee") granted the Reporting Person Performance Stock Units ("PSUs"), the vesting of which was subject to the achievement of certain corporate performance goals and time-based vesting. On January 18, 2023, the Committee determined that certain performance goals of the PSUs had been achieved. The PSUs are further subject to a time-based vesting schedule. The PSUs will vest in full on the first anniversary of the grant date subject to continued employment through such date. Upon vesting and settlement of the PSUs, the Reporting Person will receive a number of shares of common stock of the Issuer equal to the number of PSUs that have vested. Read SEC document |
| January 13, 2023 Filed Jan 17, 2023 22:37 UTC |
Szekeres David LeslieEVP, Chief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 4,564 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-003564 · doc4.xml · derivative · entry 6 Szekeres David Leslie · CIK 0001602459 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,500 Underlying: Common Stock · 4,564 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F5 · derivative.exercise_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021). F5 · derivative.expiration_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021). Read SEC document |
| January 13, 2023 Filed Jan 17, 2023 22:37 UTC |
Szekeres David LeslieEVP, Chief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-003564 · doc4.xml · derivative · entry 5 Szekeres David Leslie · CIK 0001602459 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,750 Underlying: Common Stock · 1,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020). F4 · derivative.expiration_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020). Read SEC document |
| January 13, 2023 Filed Jan 17, 2023 22:37 UTC |
Szekeres David LeslieEVP, Chief Operating Officer
|
Tax withholdingCommon Stock | 2,012 | $3.17 | $6,378.04 |
DisclosureSEC source: 0001209191-23-003564 · doc4.xml · nonDerivative · entry 4 Szekeres David Leslie · CIK 0001602459 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,150 F3 · acquired: Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions. Read SEC document |
| January 13, 2023 Filed Jan 17, 2023 22:37 UTC |
Szekeres David LeslieEVP, Chief Operating Officer
|
Exercise / conversionCommon Stock | 4,564 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-003564 · doc4.xml · nonDerivative · entry 3 Szekeres David Leslie · CIK 0001602459 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,162 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| January 13, 2023 Filed Jan 17, 2023 22:37 UTC |
Szekeres David LeslieEVP, Chief Operating Officer
|
Exercise / conversionCommon Stock | 1,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-003564 · doc4.xml · nonDerivative · entry 2 Szekeres David Leslie · CIK 0001602459 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,598 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| January 13, 2023 Filed Jan 17, 2023 22:36 UTC |
Quart Barry DDirector · Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 16,122 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-003563 · doc4.xml · derivative · entry 6 Quart Barry D · CIK 0001384243 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,807 Underlying: Common Stock · 16,122 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F5 · derivative.exercise_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021). F5 · derivative.expiration_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021). Read SEC document |
| January 13, 2023 Filed Jan 17, 2023 22:36 UTC |
Quart Barry DDirector · Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 3,645 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-003563 · doc4.xml · derivative · entry 5 Quart Barry D · CIK 0001384243 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,521 Underlying: Common Stock · 3,645 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020). F4 · derivative.expiration_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020). Read SEC document |
| January 13, 2023 Filed Jan 17, 2023 22:36 UTC |
Quart Barry DDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 5,219 | $3.17 | $16,544.23 |
DisclosureSEC source: 0001209191-23-003563 · doc4.xml · nonDerivative · entry 4 Quart Barry D · CIK 0001384243 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,989 F3 · acquired: Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions. Read SEC document |
| January 13, 2023 Filed Jan 17, 2023 22:36 UTC |
Quart Barry DDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 16,122 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-003563 · doc4.xml · nonDerivative · entry 3 Quart Barry D · CIK 0001384243 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,208 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| January 13, 2023 Filed Jan 17, 2023 22:36 UTC |
Quart Barry DDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 3,645 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-003563 · doc4.xml · nonDerivative · entry 2 Quart Barry D · CIK 0001384243 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,086 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| January 13, 2023 Filed Jan 17, 2023 22:36 UTC |
POYHONEN JOHNPresident & CCO
|
Exercise / conversionRestricted Stock Units · Derivative | 4,564 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-003562 · doc4.xml · derivative · entry 5 POYHONEN JOHN · CIK 0001286100 · President & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,500 Underlying: Common Stock · 4,564 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021). F4 · derivative.expiration_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021). Read SEC document |
| January 13, 2023 Filed Jan 17, 2023 22:36 UTC |
POYHONEN JOHNPresident & CCO
|
Exercise / conversionRestricted Stock Units · Derivative | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-003562 · doc4.xml · derivative · entry 4 POYHONEN JOHN · CIK 0001286100 · President & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,750 Underlying: Common Stock · 1,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020). F3 · derivative.expiration_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020). Read SEC document |
| January 13, 2023 Filed Jan 17, 2023 22:36 UTC |
POYHONEN JOHNPresident & CCO
|
Tax withholdingCommon Stock | 2,012 | $3.17 | $6,378.04 |
DisclosureSEC source: 0001209191-23-003562 · doc4.xml · nonDerivative · entry 3 POYHONEN JOHN · CIK 0001286100 · President & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,846 F2 · acquired: Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions. Read SEC document |
| January 13, 2023 Filed Jan 17, 2023 22:36 UTC |
POYHONEN JOHNPresident & CCO
|
Exercise / conversionCommon Stock | 4,564 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-003562 · doc4.xml · nonDerivative · entry 2 POYHONEN JOHN · CIK 0001286100 · President & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,858 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| January 13, 2023 Filed Jan 17, 2023 22:36 UTC |
POYHONEN JOHNPresident & CCO
|
Exercise / conversionCommon Stock | 1,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-003562 · doc4.xml · nonDerivative · entry 1 POYHONEN JOHN · CIK 0001286100 · President & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,294 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| January 13, 2023 Filed Jan 17, 2023 22:35 UTC |
Peraza LisaVP, Chief Accounting Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,933 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-003561 · doc4.xml · derivative · entry 5 Peraza Lisa · CIK 0001828266 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,761 Underlying: Common Stock · 1,933 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021). F4 · derivative.expiration_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021). Read SEC document |
| January 13, 2023 Filed Jan 17, 2023 22:35 UTC |
Peraza LisaVP, Chief Accounting Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 552 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-003561 · doc4.xml · derivative · entry 4 Peraza Lisa · CIK 0001828266 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,864 Underlying: Common Stock · 552 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020). F3 · derivative.expiration_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020). Read SEC document |
| January 13, 2023 Filed Jan 17, 2023 22:35 UTC |
Peraza LisaVP, Chief Accounting Officer
|
Tax withholdingCommon Stock | 1,013 | $3.17 | $3,211.21 |
DisclosureSEC source: 0001209191-23-003561 · doc4.xml · nonDerivative · entry 3 Peraza Lisa · CIK 0001828266 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,061 F2 · acquired: Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions. Read SEC document |
| January 13, 2023 Filed Jan 17, 2023 22:35 UTC |
Peraza LisaVP, Chief Accounting Officer
|
Exercise / conversionCommon Stock | 1,933 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-003561 · doc4.xml · nonDerivative · entry 2 Peraza Lisa · CIK 0001828266 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,074 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| January 13, 2023 Filed Jan 17, 2023 22:35 UTC |
Peraza LisaVP, Chief Accounting Officer
|
Exercise / conversionCommon Stock | 552 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-003561 · doc4.xml · nonDerivative · entry 1 Peraza Lisa · CIK 0001828266 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,141 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| January 13, 2023 Filed Jan 17, 2023 22:34 UTC |
MANHARD KIMBERLYDirector · EVP, Drug Development
|
Exercise / conversionRestricted Stock Units · Derivative | 4,564 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-003560 · doc4.xml · derivative · entry 6 MANHARD KIMBERLY · CIK 0001202094 · Director · EVP, Drug Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,500 Underlying: Common Stock · 4,564 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F5 · derivative.exercise_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021). F5 · derivative.expiration_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.